Navigation Links
Cancer-metabolism link runs deep in humans
Date:7/21/2010

College Park, MD (July 20, 2010) -- Eighty years ago, the medical establishment believed cancer was caused by a dysfunction of metabolism, but the idea went out of vogue. Now, scientists are again looking at metabolism and its role in cancer and other common diseases. Metabolism is a highly connected network of reactions that are arranged in parallel and interacting pathways. Such parallelism can mask how genes are linked with disease traits and make it difficult to treat conditions.

In a paper in the journal CHAOS, which is published by the American Institute of Physics, researchers at Harvard Medical School and Boston University analyzed ways to "break" the multiple parallel pathways of a metabolic network. The team applied a novel network algorithm to a published genome-scale model of human metabolism to design minimal "knockouts" for a wide variety of metabolic functions, such as phospholipid biosynthesis and the role of fumarase in suppressing human cancer.

The research suggests that the many pathways in the human metabolic network buffer each other to a striking degree, inducing "deep" epistasis -- the suppression of a mutation by one or more seemingly unrelated genes. Their results identify specific in vivo perturbation experiments that could confirm this deep parallelism in human metabolic pathways. "The results of our analysis could also be used to statistically probe complex relationships between genetic variation and disease," says co-author Marcin Imielinski.


'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1

Related medicine news :

1. Hallmark Alzheimers disease changes found in retinas of humans and imaged in live animals
2. Caring for Diabetic Pets Helps Humans Get Healthier
3. McGill-UBC project creates mouse grimace scale to help identify pain in humans and animals
4. Tiny Fish Might Help Humans Fix Damaged Hearts
5. Humans Tree-Dwelling Ancestors May Have Also Walked Upright
6. Dolphins May Warn of Health Risks in Humans
7. New drug for kidney transplant recipients effective in humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5-star rating ... , As the stress of modern life continually makes more demands on time and ... artificial stimulants can trap people in vicious high/low cycles and can also cause long ...
(Date:8/21/2017)... ... August 22, 2017 , ... PracticeMatch, a company that provides online ... with physicians and advanced practitioners like nurse practitioners and physician assistants ... through November of this year. The online career fairs will allow job seekers to ...
(Date:8/21/2017)... ... 21, 2017 , ... Los Angeles area medical group Beverly ... year 2017-2018, Christina M. Busuito, M.D. and Lukasz Swistun, M.D. This one year ... Reconstructive Surgery. The candidate will have the opportunity to work with leading ...
(Date:8/21/2017)... California (PRWEB) , ... August 21, 2017 , ... Five ... money and awareness for Alzheimer’s Family Center. , Guests will be able to ... Newport Beach Plaza, Braised Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce & ...
(Date:8/21/2017)... ... ... The experts have spoken. Prolonged sitting and standing are a no-no for ... healthy way these days? FlexiSpot, one of the fastest-growing manufacturers of ergonomic office solutions, ... Deskcise Pro™– the world’s first sit-stand-cycle desk to backers worldwide. , The Launch , ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one ... by Crain,s Detroit Business . The annual ... three-year revenue growth. This year,s edition measures growth from 2013 ... the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... said Phil Hagerman , CEO and chairman of Diplomat. ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
(Date:7/27/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: ... second-quarter 2017 and updated financial guidance for the full-year ... Highlights Reported net sales of $397.6 ... quarter. Net sales at constant currency (organic) grew by ... $0.51, compared to $0.60 in the prior-year quarter. Second-quarter ...
Breaking Medicine Technology: